Active	Status	Sponsor type	Region	Phase	Filter
5 Active 7 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Cui, Yimin
NCT05148091: The Safety, Tolerability and Immunogenicity of COVID-19 Vaccine (SCTV01C) in Healthy, Unvaccinated Adults	Completed	1/2	478	RoW	SCTV01C, Adjuvant, SCT-VA02B, Saline	Sinocelltech Ltd.	COVID-19	08/23	08/23
NCT05531097: Ascending Single-Dose and Multiple-Dose Study to Evaluate HSK31679 in Healthy Subjects and Subjects With Elevated LDL-C	Completed	1	96	RoW	HSK31679, Placebo	Haisco Pharmaceutical Group Co., Ltd.	Healthy, Elevated LDL-C	09/22	12/22
NCT05193201: A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease	Not yet recruiting	1	54	RoW	recombinant human thrombopoietin injection, rhTPO	Shenyang Sunshine Pharmaceutical Co., LTD.	Liver Disease Chronic, Thrombocytopenia	10/22	12/22
NCT05116410: A Study of HS-20094 in Healthy Participants	Recruiting	1	68	RoW	HS-20094, HS-20094 injection, Placebo, Placebo injection	Jiangsu Hansoh Pharmaceutical Co., Ltd.	Type 2 Diabetes	10/22	12/22
NCT05548231: A Study of LY3437943 in Chinese Participants With Obesity Or Overweight	Completed	1	32	RoW	LY3437943, Placebo	Eli Lilly and Company	Overweight, Obesity	07/23	07/23
Pang, Xiaocong
No trials found